NBNicolau Beckmann

Nicolau Beckmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nicolau Beckmann has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Bruno Tigani

    Novartis Institutes for BioMedical Research, Discovery Technologies, Basel, Switzerland

    8 shared publications
  • Lazzaro Mazzoni

    Respiratory Diseases Department, Novartis Institutes for BioMedical Research, Lichtstr. 35, WSJ-386.5.10, CH-4002 Basel, Switzerland

    4 shared publications
  • Catherine Cannet

    Novartis Institutes for BioMedical Research, Discovery Technologies, Basel, Switzerland

    3 shared publications
  • John R Fozard

    Respiratory Diseases Area, Novartis Institutes for BioMedical Research, CH-4002, Basel, Switzerland

    3 shared publications
  • Markus Rudin

    3 shared publications
  • D. Baumann

    Central Technologies, Novartis Institutes for Biomedical Research, CH‐4002 Basel, Switzerland

    2 shared publications

Latest Publications

  • Near‐infrared fluorescence imaging and histology confirm anomalous edematous signal distribution detected in the rat lung by MRI after allergen challenge

    by Bruno Tigani, Hans‐Ulrich Gremlich, Catherine Cannet, Stefan Zurbruegg, Harry Karmouty Quintana, Nicolau Beckmann

    Purpose To address the issue concerning the predominant location, on the left anatomic side, of edematous signals detected by magnetic resonance imaging (MRI) in the lungs of actively sensitized rats following intratracheal (IT) allergen challenge. Materials and Methods Near‐infrared fluorescence (NIRF) imaging was used to detect the lobular distribution in the lungs of normal rats of an IT instilled fluorescent dye, Cy5.5. Actively sensitized Brown Norway rats were examined by MRI 24 hours after IT administration of ovalbumin. The perivascular edema was quantified by histology in the different lobes of lungs removed from the same animals immediately after the MRI acquisitions. Results An uneven distribution of Cy5.5 was found, predominantly on the left lobe, paralleling the localized development of allergic pulmonary inflammation in the left lobe detected as edematous signal by MRI and confirmed by histology. The patterns of the distributions of the dye between and within the lobes were very similar to those of perivascular edema assessed histologically. Conclusion The data indicate a relationship between the molecular deposition of the dye detected by NIRF in the lungs and the distribution of allergen eliciting the development of pulmonary inflammation in actively rats. The combination of MRI with NIRF imaging may provide important information in preclinical pharmacologic research in the area of airway diseases. While MRI is able to address the effects of compounds on the inflammatory response in models of airways diseases, NIRF imaging may provide important insights on drug distribution and interaction in the lung, being thus suited for molecular imaging studies. J. Magn. Reson. Imaging 2004;20:967–974.


  • Magnetic resonance imaging in drug discovery: lessons from disease areas

    by Nicolau Beckmann, Didier Laurent, Bruno Tigani, Rogério Panizzutti, Markus Rudin


  • Effects of a mitogen-activated protein kinase inhibitor on allergic airways inflammation in the rat studied by magnetic resonance imaging

    by Bruno Tigani, Franco Di Padova, Stefan Zurbrügg, Elisabeth Schaeublin, Laszlo Revesz, John R Fozard, Nicolau Beckmann


  • Age-Dependent Cerebrovascular Abnormalities and Blood Flow Disturbances in APP23 Mice Modeling Alzheimer's Disease

    by Nicolau Beckmann, Alexandra Schuler, Thomas Mueggler, Eric P. Meyer, Karl-Heinz Wiederhold, Matthias Staufenbiel, Thomas Krucker

    Neuropathological changes associated with Alzheimer's disease (AD) such as amyloidplaques, cerebral amyloid angiopathy, and related pathologies are reproduced in APP23 transgenic mice overexpressing amyloid precursor protein (APP) with the Swedish mutation. Magnetic resonance angiography (MRA) was applied to probe,in vivo, the cerebral arterial hemodynamics of these mice. Flow voids were detected at the internal carotid artery of 11-month-old APP23 mice. At the age of 20 months, additional flow disturbances were observed in large arteries at the circle of Willis. Vascular corrosion casts obtained from the same mice revealed that vessel elimination, deformation, or both had taken place at the sites where flow voids were detected by MRA. The detailed three-dimensional architecture of the vasculature visible in the casts assisted the identification of smaller vessels most likely formed as substitution or anastomosis within the circle of Willis. Angiograms and corrosion casts from nontransgenic, age-matched mice manifested no major abnormalities in the cerebrovascular arterial flow pattern. Because no transgene overexpression has been found in the cerebrovasculature of APP23 mice and no deposits of amyloid-β (Aβ) were observed in large arteries in the region of the circle of Willis, the present results suggest that soluble Aβ may exert deleterious effects on the vasculature. Our findings support the idea that cerebral circulatory abnormalities evolving progressively could contribute to AD pathogenesis. The study also shows the power of MRA to identify changes of vascular function in genetically engineered mice. MRA as a noninvasive technique could be applied to test new therapeutic concepts in animal models of AD and in humans.


  • Resolution of the oedema associated with allergic pulmonary inflammation in rats assessed noninvasively by magnetic resonance imaging

    by Bruno Tigani, Catherine Cannet, Stefen Zurbrügg, Elisabeth Schaeublin, Lazzaro Mazzoni, John R Fozard, Nicolau Beckmann

    Magnetic resonance imaging (MRI) was used to study noninvasively the effects of compounds to resolve inflammation induced by ovalbumin (OVA) challenge in the lungs of actively sensitised rats. Marked oedematous signals were detected between 24 and 96 h following OVA in vehicle‐treated animals. When administered 24 h after OVA, budesonide, a glucocorticosteroid, or 4‐(8‐benzo[1,2,5]oxadiazol‐5‐yl‐[1,7]naphthyridin‐6‐yl)‐benzoic acid (NVP‐ABE171), a selective phosphodiesterase 4 inhibitor, increased the rate of resolution of established oedematous signals detected by MRI. The effect was evident 3 h after drug administration and the signals were nearly fully resolved at 96 h postchallenge. The drug‐induced rapid resolution of MRI signals was not accompanied by changes in parameters of inflammation in the bronchoalveolar lavage fluid, but was associated with perivascular oedema detected histologically. In conclusion, the effects of anti‐inflammatory drugs on a component of allergic inflammation can be monitored by following with MRI the rate of resolution of the associated oedematous signals. British Journal of Pharmacology (2003) 140, 239–246. doi:10.1038/sj.bjp.0705429


  • Open Access

    Macrophage infiltration into the rat knee detected by MRI in a model of antigen‐induced arthritis

    by Nicolau Beckmann, Regina Falk, Stefan Zurbrügg, Janet Dawson, Petra Engelhardt

    Three‐dimensional (3D) MR images were obtained from the knees of rats in a model of antigen‐induced arthritis, elicited by the intraarticular administration of methylated bovine serum albumin (mBSA) to previously immunized rats. Superparamagnetic particles of iron oxide (SPIO) were administered i.v. 24 hr before each imaging session. Starting 4 days postantigen injection, images from arthritic knees exhibited distinctive signal attenuation in the synovium. This signal attenuation was significantly smaller in knees from animals treated with dexamethasone, a glucocorticosteroid, and completely absent in contralateral knees that had been challenged with vehicle. A significant negative correlation was found between the MRI signal intensity in the synovium and the histologically determined iron content in macrophages located in the same region. These results suggest the feasibility of detecting macrophage infiltration into the knee synovium in this model of antigen‐induced arthritis by labeling the cells with SPIO. This readout could provide an early marker of disease progression, before more aggressive changes like cartilage and bone erosion take place. Monitoring early changes associated with arthritis can have an impact in preclinical studies by shortening the duration of the experimental period and by facilitating the investigation of novel immunomodulatory therapies acting on macrophages. Also, the approach can be potentially adapted to clinical studies. Magn Reson Med 49:1047–1055, 2003.


  • Open Access

    Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation

    by N. Beckmann, C. Cannet, M. Fringeli‐Tanner, D. Baumann, C. Pally, C. Bruns, H.‐G. Zerwes, E. Andriambeloson, M. Bigaud

    Anatomical and functional information (renography, perfusion) was obtained by MRI in a life‐supporting transplantation model, in which Lewis rats received kidneys from Fisher 344 donors. Renography and perfusion analyses were carried out with Gd‐DOTA and small particles of iron oxide (SPIO), respectively. Starting 12 weeks posttransplantation, images from grafts of untreated recipients exhibited distinctive signal attenuation in the cortex. Animals treated with cyclosporin (Sandimmune Neoral; Novartis Pharma, Basel, Switzerland) to prevent acute rejection showed a signal attenuation in the cortex at 33 weeks posttransplantation, while kidneys from rats treated additionally with everolimus (Certican; Novartis), a rapamycin derivative, had no changes in anatomical appearance. A significant negative correlation was found between the MRI cortical signal intensity and the histologically determined iron content in macrophages located in the cortex. Renography revealed a significantly reduced functionality of the kidneys of untreated controls 33 weeks after transplantation, while no significant changes in perfusion were observed in any group of rats. These results suggest the feasibility, by labeling macrophages with SPIO, of detecting signs of graft rejection significantly earlier than when changes in function occur. Monitoring early changes associated with chronic rejection can have an impact in preclinical studies by shortening the duration of the experimental period and by facilitating the investigation of novel immunomodulatory therapies for transplantation. Magn Reson Med 49:459–467, 2003.


  • Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI

    by Nicolau Beckmann, Bruno Tigani, Rosemary Sugar, Alan D. Jackson, Gareth Jones, Lazzaro Mazzoni, John R. Fozard

    Using magnetic resonance imaging (MRI), we detected a signal in the lungs of Brown Norway rats after intratracheal administration of endotoxin [lipopolysaccharide (LPS)]. The signal had two components: one, of diffuse appearance and higher intensity, was particularly prominent up to 48 h after LPS; the second, showing an irregular appearance and weaker intensity, was predominant later. Bronchoalveolar lavage fluid analysis indicated that generalized granulocytic (especially neutrophilic) inflammation was a major contributor to the signal at the early time points, with mucus being a major factor contributing at the later time points. The facts that animals can breathe freely during data acquisition and that neither respiration nor cardiac triggering is applied render this MRI approach attractive for the routine testing of anti-inflammatory drugs. In particular, the prospect of noninvasively detecting a sustained mucus hypersecretory phenotype in the lung brings an important new perspective to models of chronic obstructive pulmonary diseases in animals.